Pharma Journalist -

Karyopharm Therapeutics Inc. and the Menarini Group announced that the European Commission (EC) has granted orphan medicinal product designation for selinexor for the treatment of…
Read More...

Intrinsic Medicine, Inc. (Intrinsic), a therapeutics company leveraging human milk biology to transform Gut-Brain Axis (GBA) and inflammatory disorders, and Phoenix Biotech Acquisition…
Read More...

Dyne Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for DYNE-251 for the treatment of Duchenne muscular dystrophy (DMD)…
Read More...

Roche announced positive topline results from two global phase III studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo (faricimab), in…
Read More...

Outlook Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for filing a Biologics License Application (BLA) for ONS-5010 / LYTENAVA…
Read More...

AbbVie announced that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) for epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous…
Read More...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat…
Read More...

Telix announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensland (UQ), to develop a radiolabelled molecule targeting an…
Read More...

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to invest $59 million to significantly expand its laboratory…
Read More...

PTC Therapeutics, Inc. announced that it has entered into a strategic financing collaboration with funds managed by Blackstone to support its mission to reach a steady-state of…
Read More...